OMVOH Trademark

Trademark Overview


On Tuesday, December 17, 2019, a trademark application was filed for OMVOH with the United States Patent and Trademark Office. The USPTO has given the OMVOH trademark a serial number of 88729726. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by Eli Lilly and Company. The OMVOH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
omvoh

General Information


Serial Number88729726
Word MarkOMVOH
Filing DateTuesday, December 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
Translation of Words in MarkThe wording "OMVOH" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 21, 2022SOU EXTENSION 5 GRANTED
Wednesday, November 23, 2022SOU EXTENSION 5 FILED
Wednesday, November 23, 2022TEAS EXTENSION RECEIVED
Tuesday, May 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 23, 2022SOU EXTENSION 4 GRANTED
Wednesday, May 18, 2022SOU EXTENSION 4 FILED
Wednesday, May 18, 2022TEAS EXTENSION RECEIVED
Saturday, November 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 18, 2021SOU EXTENSION 3 GRANTED
Thursday, November 18, 2021SOU EXTENSION 3 FILED
Thursday, November 18, 2021TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2021SOU EXTENSION 2 GRANTED
Monday, May 17, 2021SOU EXTENSION 2 FILED
Monday, May 17, 2021TEAS EXTENSION RECEIVED
Friday, December 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 1 GRANTED
Tuesday, November 17, 2020SOU EXTENSION 1 FILED
Thursday, December 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 17, 2020TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2020ASSIGNED TO LIE
Thursday, March 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 5, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, March 5, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 5, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, March 5, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, March 5, 2020ASSIGNED TO EXAMINER
Friday, December 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 20, 2019NEW APPLICATION ENTERED